Filing metadata

Accession number
0000947871-22-000254
Form type
Form 4
Filer
Kinnate Biopharma Inc.
CIK
CIK 1797768
Filed
Feb 15, 2022
Reporting period
Feb 11, 2022
Description
Insider transaction

Explore SEC Filings Hub